Is TTNP a good stock to buy?
Maxim Group is very positive about TTNP and gave it a “Hold – Buy” rating on Feb 25, 2021. The price target was set to $11.00….Predicted Opening Price for Titan Pharmaceuticals of Monday, November 8, 2021.
|Fair opening price November 8, 2021||Current price|
Will Titan Pharmaceuticals stock go up?
Will Titan Pharmaceuticals, Inc. (de) stock price grow / rise / go up? Yes. The TTNP stock price can go up from 1.720 USD to 1.918 USD in one year.
Who owns Ttnp stock?
Top 10 Owners of Titan Pharmaceuticals Inc
|The Vanguard Group, Inc.||2.07%||204,306|
|Morgan Stanley & Co. LLC||1.61%||158,773|
|Citadel Advisors LLC||0.70%||68,908|
|Geode Capital Management LLC||0.54%||53,097|
Will Ttnp reverse split?
(NASDAQ: TTNP) (“Titan” or the “Company”) today announced that its Board of Directors has approved a 1-for-30 reverse stock split of the Company’s common stock, which will be effective at 5:00 p.m. Eastern Time on Monday, November 30, 2020.
When did Titan Pharmaceuticals go public?
The Company’s shares will begin trading on a split-adjusted basis on the Nasdaq Capital Market commencing upon market open on December 1, 2020.
How many shares does Ttnp have?
(US:TTNP) has 37 institutional owners and shareholders (aka shareholding pattern) that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 584,117 shares.
What is a 1 for 30 reverse stock split?
Reverse stock split ratio or RSP is 1:30; original share price or OP is $2; Original Number of Shares or OS is 2400000. New price per-share or NP = OP X The number of shares consolidated = 2 X 30 = $60. New number of shares or NS = OS ÷ RSP = 2400000 × (1 ÷ 30) = 80000 shares.
Who owns Titan Pharmaceuticals?
Common Stock (TTNP) Institutional Holdings | Nasdaq….New and Sold Out Positions.
|OWNER NAME||MORGAN STANLEY|
|VALUE (IN 1,000S)||$287|
Is Titan Pharmaceuticals doing a reverse split?
The Company’s stockholders approved the reverse stock split at a Special Meeting of Stockholders on November 30, 2020. The Company’s shares will begin trading on a split-adjusted basis on the Nasdaq Capital Market commencing upon market open on December 1, 2020.
Is Titan Pharmaceuticals A Good Investment?
Titan Pharmaceuticals has received a consensus rating of Buy.